Caesarean Myomectomy: Feasibility and safety

Area of Science:

• Obstetrics and Gynecology
• Reproductive Surgery

Background:

• Caesarean myomectomy is traditionally avoided due to hemorrhage and morbidity concerns.
• Recent studies suggest myomectomy during Caesarean section is feasible without increased risks.

Purpose of the Study:

• To evaluate the safety and efficacy of myomectomy performed concurrently with Caesarean section.
• To assess perioperative management and postoperative morbidity in cases of Caesarean myomectomy.

Main Methods:

• A case series of 8 women undergoing myomectomy during Caesarean section for large lower segment fibroids.
• Detailed review of antenatal course, surgical procedures, and postoperative outcomes.

Main Results:

• Myomectomy added minimal time (15 min) and hospital stay (1 day) with no significant morbidity.
• Despite large fibroid sizes (7/8 >5 cm), no hysterectomies were required.
• Good neonatal outcomes were observed in all cases.

Conclusions:

• Caesarean myomectomy is a safe and effective procedure for selected patients in tertiary care settings.
• Experienced surgical teams can successfully manage myomectomy during Caesarean delivery, even for large fibroids.